Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines

Valdes-Balbin, Y; Santana-Mederos, D; Paquet, F; Fernandez, S; Climent, Y; Chiodo, F; Rodriguez, L; Ramirez, BS; Leon, K; Hernandez, T; Castellanos-Serra, L; Garrido, R; Chen, GW; Garcia-Rivera, D; Rivera, DG; Verez-Bencomo, V

Valdes-Balbin, Y; Garcia-Rivera, D; Verez-Bencomo, V (corresponding author), Finlay Vaccine Inst, Havana 11600, Cuba.; Rivera, DG (corresponding author), Univ Havana, Fac Chem, Lab Synthet & Biomol Chem, Havana 10400, Cuba.; Paquet, F (corresponding author), Ctr Natl Rech Sci, Ctr Biophys Mol, UPR 4301, F-45071 Orleans, France.

ACS CENTRAL SCIENCE, 2021; 7 (5): 757

Abstract

The development of recombinant COVID-19 vaccines has resulted from scientific progress made at an unprecedented speed during 2020. The recombinant spi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索